Key Financial’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
Key Financial's TCRT Position: Q3 2026 in Review
Key Financial held its Alaunos Therapeutics (TCRT) position steady in Q3 2026 at 24 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #1300.
Key Financial first reported a position in TCRT in Q1 2020 and has held it in 22 quarters since. The position peaked at $13K in Q1 2021. 24 funds tracked by Wall St. Rank hold TCRT as of Q3 2026.
- Key Financial held 24 shares of Alaunos Therapeutics worth $21 as of Q3 2026.
- Key Financial left its Alaunos Therapeutics share count unchanged in Q3 2026.
- Alaunos Therapeutics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1300 holding.
- Key Financial first reported a position in Alaunos Therapeutics in Q1 2020 and has held it in 22 quarters since.
- Key Financial's Alaunos Therapeutics position peaked at $13K in Q1 2021.
- 24 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.